The Evidence Speaks (May 2020)
This edition includes: substance use changes with opioid agonist therapy; palliative care in the ICU; and priorities of patients with glomerular disease
Read MoreJuly 31, 2019
This edition includes: substance use changes with opioid agonist therapy; palliative care in the ICU; and priorities of patients with glomerular disease
Read More
The 31st edition summarizes some of the latest research from CHÉOS Scientists, including epinephrine and out-of-hospital cardiac arrest, kidney disease treatment, and barriers to post-procedure cardiac care.
Read More
Drs. Sarah Munro, Joseph Puyat, and Wei Zhang received funding from the Michael Smith Foundation for Health Research this week
Read More
The 29th edition summarizes some of the latest research from CHÉOS Scientists, including patient preferences for rheumatoid arthritis prevention, a kidney disease risk-prediction tool, and sleep disturbance in adolescents.
Read More
Read about the Scientists and research that appeared in the media over the month.
Read More
Several CHÉOS Scientists will be front and centre at this year's BC Kidney Days event, taking place on November 1.
Read More
Drs. Anne Gadermann, Ehsan Karim, and Skye Barbic were recently announced as 2018 MSFHR Scholars
Read More
The twelfth installment in our series, "The Evidence Speaks," highlighting the latest in CHÉOS research.
Read More
The tenth installment in our series, "The Evidence Speaks," highlighting the latest in CHÉOS research.
Read More
The sixth installment in our new series, "The Evidence Speaks," highlighting the latest in CHÉOS research.
Read More